Small-Cap Stock Watch: Key Catalysts This Week (February 9–13)

From corporate updates to investor events, we’ve tracked the full scope of small-cap catalysts slated for the week ahead.

--

Companies with Material Events This Week

● XAIR — Will participate in the 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, taking place from February 9–11, 2026, in Snowbird, Utah.

● AQMS — Members of the executive and technical teams will participate in the NAATBatt 2026 Annual Meeting, held February 9–12, 2026, in Tucson, Arizona. The meeting convenes stakeholders across the battery and energy storage ecosystem to discuss market trends, technology development, and the future of advanced battery supply chains.

● ELBM — The leadership team will attend Investing in African Mining Indaba 2026 from February 9–12, 2026. During the conference, the company will engage in discussions regarding future cobalt hydroxide feed supply for its North American refinery, including contractual arrangements targeting initial deliveries beginning in 2027.

● DCOY — Will participate in the Corporate Connect Webinar Series hosted by Webull Financial, held virtually from February 10–11, 2026. CEO Rick Pierce will provide a corporate overview highlighting the company’s novel antiviral therapeutics designed to target multiple viral pathogens with a single drug.

● AKTX — Will participate in the Corporate Connect Webinar Series hosted by Webull Financial from February 10–11, 2026. CEO Abizer Gaslightwala will present an overview of the company’s ADC platform, including AKTX-101 and AKTX-102, and discuss IND-enabling activities supporting a first-in-human trial planned for late 2026 or early 2027.

● ADGM — Management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 10, 2026, in Snowbird, Utah.

● SNTI — Timothy Lu, M.D., Ph.D., Co-Founder and CEO, will deliver an on-stage company presentation at the Healthcare Conference Taipei 2026, held February 10–11, 2026, at the Regent Taipei Hotel. The presentation will take place on February 10, 2026, from 10:30–10:40 AM local time and will highlight the company’s Gene Circuit platform and partnership opportunities.

● GRWG — Will participate in IgniteIt Spotlight: New Jersey, held February 10, 2026, in Jersey City, New Jersey. David Todd, Vice President of Enterprise Solutions, will join a panel discussion at 10:30 AM ET focused on genetics, terpenes, and cultivation strategy.

● SPAI — Will present at the Defence Leaders Combat Engineer & Logistics Conference (CEL26), taking place February 10–12, 2026, in Krakow, Poland. The company will showcase its AI and computer vision technologies supporting demining, mission planning, and force protection.

● APYX — Management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 10, 2026, in Snowbird, Utah.

● ISPR — Has been invited by the FDA to participate in an invitation-only Roundtable Discussion with Small ENDS Manufacturers on PMTA submissions, taking place February 10, 2026. Participation is limited to 30 companies nationwide.

● VTAK — Its LockeT suture retention device will be featured during live procedural cases at the Structural Heart Intervention and Imaging: A Practical Approach 2026 conference, held February 11–13, 2026, in San Diego, California.

● GRI — Will participate in the Corporate Connect Webinar Series hosted by Webull Financial, held virtually February 10–11, 2026.

● AIM — Will participate in the Corporate Connect Webinar Series hosted by Webull Financial from February 10–11, 2026. CEO Thomas K. Equels will present a corporate overview with a focus on pancreatic cancer strategy.

● MBRX — Will participate in the Corporate Connect Webinar Series hosted by Webull Financial, held virtually February 10–11, 2026.

● IFRX — Will participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026, taking place February 11–12, 2026, in New York, New York, including a fireside chat on February 11 at 11:30 AM ET.

● FFAI — Global President Jerry Wang will participate in the Wolfe Research Auto, Auto Tech and Semiconductor Conference on Wednesday, February 11, 2026, in New York City.

● CCCC — Management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026, held February 11–12, 2026, in New York, New York.

● ZNTL — Management will participate in a fireside discussion at the Guggenheim Emerging Outlook: Biotech Summit on February 11, 2026, at 3:30 PM ET in New York, New York.

● SGMT — Will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, New York, on February 11, 2026, including a fireside chat at 10:00 AM ET.

● RZLT — Management will participate in the Guggenheim Emerging Outlook: Biotech Summit from February 11–12, 2026, in New York, New York, and will hold one-on-one investor meetings throughout the conference.

● SABS — Will participate in the Guggenheim Securities Emerging Outlook: Biotech Summit on February 11, 2026, at 10:30 AM ET, in New York, New York, in a fireside chat format.

● IRD — Will present at Advanced Therapies Week Conference on February 11, 2026, from 10:30–11:00 AM PT, in San Diego, California. The presentation will focus on scalable viral vector manufacturing models.

● NMRA — Will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on February 11, 2026, at 4:00 PM ET in New York, New York.

● FMFC — Management, including Chairman Duncan Miao, will present at the Skyline Signature Series on Thursday, February 12, 2026, at 11:00 AM ET.

● INAB — Will present at the IO360° Conference on Thursday, February 12, 2026, from 1:20–1:40 PM ET, during the IO Clinical Advancements Plenary session.

● BOLD — CEO Zachary Hornby will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, at 3:00 PM ET in New York, New York.

● STTK — Management will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium, held February 12–13, 2026.

● CABA — Will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, at 9:30 AM ET in New York, New York.

● CLYM — Will participate in a fireside chat at Guggenheim’s Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, from 3:00–3:25 PM ET.

]● XFOR — Management will participate in the Guggenheim Emerging Outlook: Biotech Summit from February 11–12, 2026, in New York, New York, including a fireside chat on February 12 at 12:30 PM ET and one-on-one meetings.

● NKLR — Representatives will attend WNIC-SMR Europe from February 10–11, 2026, in London, UK, and the USNIC Advanced Reactor Summit from February 10–12, 2026, in Seattle, Washington.

● AKBA — Members of the executive team will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, at 9:30 AM ET.

● ACRS — CEO Dr. Neal Walker and senior leadership will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, at 2:30 PM ET in New York, New York.

● LZM — Will attend the Investing in African Mining Indaba Conference and the 121 Mining Investment Conference from February 9–12, 2026, in Cape Town, South Africa.

● TLF — Declared a special cash dividend of $0.75 per share, payable on or about February 24, 2026, to stockholders of record as of February 9, 2026. Because the dividend exceeds 25% of the stock price, the ex-dividend date will be February 25, 2026.

● DAIC — Will participate in Manifest 2026 from February 9–11, 2026, at The Venetian in Las Vegas, where it will exhibit its Dot Matrix 3.0 Asset Intelligence platform.

● EDBL — Will participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, held February 10–12, 2026, in Rosemont, Illinois, featuring curated one-on-one meetings with retail buyers.

● VMAR — Will showcase its new Specter electric tritoon platform at the Miami International Boat Show beginning February 11, 2026, and at the Montreal Boat and Watersports Show beginning February 12, 2026.

● ELDN — President and CSO Steven Perrin, Ph.D., will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit on Thursday, February 12, 2026, at 10:00 AM ET.

● JRSH — Declared a regular quarterly cash dividend of $0.05 per share, payable on or about February 20, 2026, to stockholders of record as of February 13, 2026.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.